Diprivan
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
63323-269 -
Package NDC
63323-269-16 -
Package NDC
63323-269-37 -
Package NDC
63323-269-57 -
Package NDC
63323-269-67 -
Application number
NDA019627 -
SPL ID
45b28fb6-e455-43b8-b54e-e5d70ad3da22 -
SPL set ID
e3105799-a4b6-f3f4-e6e2-b2b29bbdb538 -
UNII
YI7VU623SF -
RxCUI
1808217 -
RxCUI
1808219 -
RxCUI
1808222 -
RxCUI
1808223 -
RxCUI
1808224 -
RxCUI
1808225 -
RxCUI
1808234 -
RxCUI
1808235
What the source publishes
- Labeler
- Fresenius Kabi USA, LLC
- Active ingredients
- PROPOFOL
- Form
- INJECTION, EMULSION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Diprivan",
"splId": "45b28fb6-e455-43b8-b54e-e5d70ad3da22",
"labels": [
{
"setId": "e3105799-a4b6-f3f4-e6e2-b2b29bbdb538",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e3105799-a4b6-f3f4-e6e2-b2b29bbdb538",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e3105799-a4b6-f3f4-e6e2-b2b29bbdb538"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Fresenius Kabi USA, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "10 VIAL in 1 BOX (63323-269-16) / 10 mL in 1 VIAL (63323-269-06)",
"package_ndc": "63323-269-16",
"identifierStatus": "well-formed",
"marketing_start_date": "20091117"
},
{
"sample": false,
"description": "10 VIAL in 1 BOX (63323-269-37) / 20 mL in 1 VIAL (63323-269-25)",
"package_ndc": "63323-269-37",
"identifierStatus": "well-formed",
"marketing_start_date": "20091117"
},
{
"sample": false,
"description": "20 VIAL in 1 BOX (63323-269-57) / 50 mL in 1 VIAL (63323-269-23)",
"package_ndc": "63323-269-57",
"identifierStatus": "well-formed",
"marketing_start_date": "20091117"
},
{
"sample": false,
"description": "10 VIAL in 1 BOX (63323-269-67) / 100 mL in 1 VIAL (63323-269-21)",
"package_ndc": "63323-269-67",
"identifierStatus": "well-formed",
"marketing_start_date": "20091117"
}
],
"productId": "63323-269_45b28fb6-e455-43b8-b54e-e5d70ad3da22",
"useDomain": "unknown",
"dosageForm": "INJECTION, EMULSION",
"productNdc": "63323-269",
"deaSchedule": null,
"genericName": "PROPOFOL",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "PROPOFOL",
"strength": "10 mg/mL"
}
],
"applicationNumber": "NDA019627",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20091117",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175975",
"N0000175681"
],
"upc": [
"0363323269210",
"0363323269258",
"0363323269067"
],
"unii": [
"YI7VU623SF"
],
"rxcui": [
"1808217",
"1808219",
"1808222",
"1808223",
"1808224",
"1808225",
"1808234",
"1808235"
],
"spl_set_id": [
"e3105799-a4b6-f3f4-e6e2-b2b29bbdb538"
],
"pharm_class_pe": [
"General Anesthesia [PE]"
],
"pharm_class_epc": [
"General Anesthetic [EPC]"
],
"manufacturer_name": [
"Fresenius Kabi USA, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:63323-269_45b28fb6-e455-43b8-b54e-e5d70ad3da22"